Global Antisense and RNAi Therapeutics Market Report 2021: Market to Reach $1.9 Billion by 2027 - Antisense RNA Segment is Projected to Account for $974.2 Million
30 mars 2021 07h38 HE
|
Research and Markets
Dublin, March 30, 2021 (GLOBE NEWSWIRE) -- The "Antisense and RNAi Therapeutics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global...
2021 Report on the Worldwide Industry for Single Cell Genomics to 2025 - Significant Interest in Multi-omics
16 févr. 2021 04h58 HE
|
Research and Markets
Dublin, Feb. 16, 2021 (GLOBE NEWSWIRE) -- The "Single Cell Genomics Markets" report has been added to ResearchAndMarkets.com's offering. This report, Single Cell Genomics Markets, provides the...
World RNAi Market 2020-2025: Oncology is Expected to Hold Significant Market Share in the Therapeutics Type Area
31 août 2020 05h44 HE
|
Research and Markets
Dublin, Aug. 31, 2020 (GLOBE NEWSWIRE) -- The "RNA-interference (RNAi) Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The...
Circulomics Awarded $1.5M Phase II SBIR to Develop Multiplex microRNA Assay
13 mai 2015 09h17 HE
|
Circulomics
BALTIMORE, MD--(Marketwired - May 13, 2015) - Circulomics Inc has been awarded a $1.5M Phase II Small Business Innovation Research (SBIR) grant by the National Institutes of Health (NIH) - National...
Circulomics Awarded Phase I SBIR to Develop Nanobind DNA Extraction Technology
30 avr. 2014 10h12 HE
|
Circulomics
BALTIMORE, MD--(Marketwired - April 30, 2014) -
Circulomics Inc has been awarded a Phase I Small Business Innovative Research (SBIR) grant by the National...
Circulomics Awarded Nearly $1M to Develop Multiplex MicroRNA Assay
10 déc. 2012 09h21 HE
|
Circulomics Inc
BALTIMORE, MD --(Marketwire - December 10, 2012) -
Circulomics Inc has been awarded two Small Business Innovative Research (SBIR) Phase I awards, totaling $800k...
CombiMatrix Announces Positive Preliminary Data on Non-Invasive, Cancer Screening Test
26 févr. 2009 06h00 HE
|
CombiMatrix Corporation
MUKILTEO, Wash., Feb. 26, 2009 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) today announced positive preliminary data on its investigational Comprehensive Cancer Array (CCA) test showing...